Pharmacokinetics of cannabinoids.
@article{Mcgilveray2005PharmacokineticsOC, title={Pharmacokinetics of cannabinoids.}, author={I. Mcgilveray}, journal={Pain research & management}, year={2005}, volume={10 Suppl A}, pages={ 15A-22A } }
Delta-9-tetrahydrocannabinol (Delta-9-THC) is the main psychoactive ingredient of cannabis (marijuana). The present review focuses on the pharmacokinetics of THC, but also includes known information for cannabinol and cannabidiol, as well as the synthetic marketed cannabinoids, dronabinol (synthetic THC) and nabilone. The variability of THC in plant material (0.3% to 30%) leads to variability in tissue THC levels from smoking, which is, in itself, a highly individual process. THC… Expand
113 Citations
Toxicological properties of Δ9-tetrahydrocannabinol and cannabidiol
- Medicine
- Arhiv za higijenu rada i toksikologiju
- 2020
- 3
- PDF
Urinary cannabinoid levels during nabiximols (Sativex®)-medicated inpatient cannabis withdrawal
- Chemistry
- Forensic Toxicology
- 2016
- 15
Disposition of oral delta-9 tetrahydrocannabinol (THC) in children receiving cannabis extracts for epilepsy
- Medicine
- Clinical toxicology
- 2019
- 5
Chapter 85 – The Synthetic Analog of Δ9-Tetrahydrocannabinol (THC): Nabilone. Pharmacology and Clinical Application
- Medicine
- 2017
- 1
A cannabinoid analogue of Delta9-tetrahydrocannabinol disrupts neural development in chick.
- Biology, Medicine
- Birth defects research. Part B, Developmental and reproductive toxicology
- 2008
- 20
Human Pharmacokinetics and Adverse Effects of Pulmonary and Intravenous THC-CBD Formulations
- Medicine
- Medical Cannabis and Cannabinoids
- 2018
- 2
References
SHOWING 1-10 OF 79 REFERENCES
Pharmacokinetics and Pharmacodynamics of Cannabinoids
- Chemistry, Medicine
- Clinical pharmacokinetics
- 2003
- 845
- PDF
Blood cannabinoids. I. Absorption of THC and formation of 11-OH-THC and THCCOOH during and after smoking marijuana.
- Chemistry, Medicine
- Journal of analytical toxicology
- 1992
- 373
Bypassing the first-pass effect for the therapeutic use of cannabinoids
- Medicine
- Pharmacology Biochemistry and Behavior
- 1993
- 59
Relating Blood Concentrations of Tetrahydrocannabinol and Metabolites to Pharmacologic Effects and Time of Marijuana Usage
- Chemistry, Medicine
- Therapeutic drug monitoring
- 1993
- 86
Plasma delta‐9‐tetrahydrocannabinol concentrations and clinical effects after oral and intravenous administration and smoking
- Chemistry, Medicine
- Clinical pharmacology and therapeutics
- 1980
- 382
Marijuana smoking: effect of varying delta 9-tetrahydrocannabinol content and number of puffs.
- Chemistry, Medicine
- The Journal of pharmacology and experimental therapeutics
- 1992
- 113
The effect of orally and rectally administered delta 9-tetrahydrocannabinol on spasticity: a pilot study with 2 patients.
- Medicine
- International journal of clinical pharmacology and therapeutics
- 1996
- 138
Interactions in man of delta‐9‐tetrahydrocannabinol; II. Cannabinol and cannabidiol
- Medicine
- Clinical pharmacology and therapeutics
- 1975
- 80
Tolerance and disposition of tetrahydrocannabinol in man.
- Chemistry, Medicine
- The Journal of pharmacology and experimental therapeutics
- 1980
- 189